Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.45
(
-1.20%
)
Bitcoin
73,925.75
(
-0.02%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 64975

Sunday, 08/03/2008 1:03:24 PM

Sunday, August 03, 2008 1:03:24 PM

Post# of 257253
>The T franchise is now burdened with the risk that sales will be discontinued. Pulling the drug could happen any time.<

The salient point, IMO, is that Tysabri will not reach the stated goal of 100,000 patients in 2010 and it probably won’t even come close.

Whether Ty would have reached this goal in any case was debatable, but now the chances of its doing so are virtually nil.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now